RHÖN-KLINIKUM AG

- Ad hoc - RHÖN-KLINIKUM AG: City of Wiesbaden in favour of RHÖN-KLINIKUM AG acquiring equity interest in Dr. Horst Schmidt Kliniken

RHÖN-KLINIKUM AG

• City of Wiesbaden in favour of RHÖN-KLINIKUM AG acquiring equity interest in Dr. Horst Schmidt Kliniken 
• Outlook for 2012 is refined

Bad Neustadt a.d. Saale, 9 February 2012 --- By a large majority, Wiesbaden City Council today gave its approval for the sale of a 49 per cent equity interest in Dr. Horst Schmidt Kliniken (HSK) to RHÖN-KLINIKUM AG. As part of this interest, the private hospital operator is to assume entrepreneurial management of the biggest hospital in Wiesbaden, Federal State Capital of Hesse, and to also initiate the refurbishment and modernisation of its building infrastructure.

“We are pleased with the tremendous trust the city councillors and Wiesbaden City Council have placed in us. With our restructuring expertise, we will return HSK to profit and make it a viable facility”, said Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG.

Each year, Dr. Horst Schmidt Kliniken treats a total of roughly 43 thousand patients in 1,027 beds and generates revenues of over EUR 200 million. As a maximum-care hospital, HSK employs roughly 3,100 employees at three sites.

Execution of the transaction requires formal approval by the social, municipal supervisory and cartel authorities, and is moreover subject to the reservation of a possible referendum opposing the share’s sale. The two parties agreed to maintain secrecy regarding the purchase price.

As part of this recent participating interest, the Group refines its forecast for the current financial year to also include a first-time consolidation of HSK slated for the second quarter of 2012.

For 2012 including HSK, RHÖN-KLINIKUM AG expects revenues of EUR 2.85 billion which may fluctuate within a range of plus or minus 2.5 per cent. This revenue target is accompanied by a forecast for EBITDA of EUR 350 million and for net consolidated profit of EUR 145 million – in each case influenced by a negative earnings contribution from the HSK consolidation and subject to a fluctuation range of plus or minus five per cent. In the event of the first-time consolidation of HSK being delayed, adjustments to individual revenue and earnings figures may become necessary during the year.

The Board of Management